| Literature DB >> 28352659 |
Antoine Seignez1,2,3, Anne-Laure Joly1,2, Killian Chaumonnot1,2, Adonis Hazoumé1,2, Michel Sanka1,2, Guillaume Marcion1,2, Christophe Boudesco1,2, Arlette Hammann1,2, Renaud Seigneuric1,2, Gaetan Jégo1,2, Patrick Ducoroy4, Patrice Delarue5, Patrick Senet5, Cristina Castilla-Llorente6, Eric Solary6,7, Marie-Agnès Durey8, Marie-Thérèse Rubio9,10, Olivier Hermine11,12, Evelyne Kohli1,2,3, Carmen Garrido1,2,13.
Abstract
Better identification of severe acute graft-versus-host disease (GvHD) may improve the outcome of this life-threatening complication of allogeneic hematopoietic stem cell transplantation. GvHD induces tissue damage and the release of damage-associated molecular pattern (DAMP) molecules. Here, we analyzed GvHD patients (n = 39) to show that serum heat shock protein glycoprotein 96 (Gp96) could be such a DAMP molecule. We demonstrate that serum Gp96 increases in gastrointestinal GvHD patients and its level correlates with disease severity. An increase in Gp96 serum level was also observed in a mouse model of acute GvHD. This model was used to identify complement C3 as a main partner of Gp96 in the serum. Our biolayer interferometry, yeast two-hybrid and in silico modeling data allowed us to determine that Gp96 binds to a complement C3 fragment encompassing amino acids 749-954, a functional complement C3 hot spot important for binding of different regulators. Accordingly, in vitro experiments with purified proteins demonstrate that Gp96 downregulates several complement C3 functions. Finally, experimental induction of GvHD in complement C3-deficient mice confirms the link between Gp96 and complement C3 in the serum and with the severity of the disease.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28352659 PMCID: PMC5358489 DOI: 10.1172/jci.insight.90531
Source DB: PubMed Journal: JCI Insight ISSN: 2379-3708